Stocks Comparison
Niagen Bioscience vs Trulieve Cannabis: revenue, profit, margins and growth compared
Niagen Bioscience brought in $129.4M of revenue in fiscal 2025, Trulieve Cannabis $1.2B in fiscal 2025. Revenue changed by +29.9% at Niagen Bioscience and -0.4% at Trulieve Cannabis on the year before, so Niagen Bioscience grew faster. Niagen Bioscience kept 13.4% of its revenue as net profit, Trulieve Cannabis -9.9%.
Side by side, latest fiscal year
| NAGE | TRLV | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $129.4M | $1.2B |
| Revenue growth | +29.9% | -0.4% |
| Net income | $17.4M | -$116.4M |
| Net margin | 13.4% | -9.9% |
| Free cash flow | n/a | $228.6M |
| Free cash flow margin | n/a | 19.4% |
| Earnings per share (diluted) | $0.20 | -$0.58 |
| Cash | $64.8M | $255.5M |
| Debt | n/a | $136.7M |
| Price to earnings | 15.3 | n/a |
| Market value | $241.3M | $2.4B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #282 of 523 · Health care | #137 of 523 · Health care |
Over the years
Questions about Niagen Bioscience and Trulieve Cannabis
Which is bigger by revenue, Niagen Bioscience or Trulieve Cannabis?
Trulieve Cannabis is bigger by revenue: $1.2B in fiscal 2025, against $129.4M for Niagen Bioscience in fiscal 2025.
Which keeps more of its revenue as profit, Niagen Bioscience or Trulieve Cannabis?
Niagen Bioscience had a net margin of 13.4% in fiscal 2025; Trulieve Cannabis had -9.9% in fiscal 2025.
Which grew revenue faster, Niagen Bioscience or Trulieve Cannabis?
In their latest fiscal years revenue changed by +29.9% at Niagen Bioscience and -0.4% at Trulieve Cannabis.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.